A licensed wholesaler specializing in medical cannabis distribution, operating with a lean business structure and established in both Germany and the UK, complying with controlled drugs and GDP requirements

Currently undertaking import/export, wholesale sales, sales distribution (pharmacies) of medical cannabis flowers & extracts and medical CBD API, as well as B2B and B2C sales of proprietary THC/CBD test kits

Developed and patented THC/CBD test kits and built a diverse product portfolio that includes flowers, extracts, and CBD isolate

A well-established customer base and has a distinctive online shop for customers, along with an online portal for doctors and pharmacists. The portal is designed to provide useful information about cannabis products and access to helpful tools and services

Strategically partnered with EU-GMP certified warehouse providers to support the labelling of flower, extract and CBD products, and fulfill orders for the EU market

Experienced, industry-leading team with deep German market expertise as well as navigating global medical cannabis and CBD markets

Includes IP/proprietary products and one brand as part of the sale

Comes complete with supply agreements and B2B contracts in place

An acquiring entity has the potential to benefit from its tax loss carry forward asset, which currently exceeds €3.2 million ($4.7 million CAD)

For clarity, the transaction would include both the German and UK businesses as one